Strategic Advisory Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Strategic Advisory Partners's IBB Position: Q3 2026 in Review
Strategic Advisory Partners reduced its iShares Biotechnology ETF (IBB) stake by 8.9% in Q3 2026, selling an estimated $184K and leaving 9,448 shares worth $1.99M. The position accounts for 1.37% of the portfolio, ranked #7.
Strategic Advisory Partners first reported a position in IBB in Q4 2025 and has held it in 4 quarters since. The position peaked at $4.93M in Q4 2025. 1,031 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Strategic Advisory Partners held 9,448 shares of iShares Biotechnology ETF worth $1.99M as of Q3 2026.
- Strategic Advisory Partners sold 919 iShares Biotechnology ETF shares in Q3 2026, an estimated $184K.
- iShares Biotechnology ETF made up 1.37% of Strategic Advisory Partners's portfolio in Q3 2026, its #7 holding.
- Strategic Advisory Partners first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 4 quarters since.
- Strategic Advisory Partners's iShares Biotechnology ETF position peaked at $4.93M in Q4 2025.
- 1,031 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Strategic Advisory Partners's 13F filing for Q3 2026, filed 6 Nov 2026.